The PEACE trial was the largest ever study evaluating the prognostic effect of OPG, and the main results of the present study show that elevated plasma OPG levels hold a long-term independent association with a composite outcome and all-cause death in patients with stable CAD, even after adjusting for the standard predictors. Here, TNFRSF11B is linked to coronary artery disorder.